[1] 李静,王秀英,孙伟.单胺氧化酶抑制剂在神经变性疾病中的研究进展[J].药物研究,2003(16):17-19. [2] HOLT A, SHARMAN D F, BAKER G B, et al.A continuous spectrophotometric assay for monoamine oxidase and related enzymes intissue homogenates[J]. Analytical biochemistry,1997,244(2):384-392. [3] JIANG Z, BARRET M O, BOYD K G, et al.JM47, a cyclic tetrapeptide HC-toxin analogue from a marine Fusarium species[J]. Cheminform, 2002, 60(1):33-38. [4] KROHN K, FAROOQ U, FLÖRKE U, et al. Secondary metabolites isolated from an endophytic Phoma sp.-Absolute configuration of tetrahydropyrenophorol using the solid-state TDDFT CD methodology[J]. European journal of organic chemistry, 2010, 2007(19):3206-3211. [5] 王志强, 杨志钧, 陈代杰,等. 应用高速逆流色谱法分离茎点霉属真菌代谢物中脂肪酸成份的研究[J]. 中国抗生素杂志, 2010, 35(6):439-441. [6] REISSINGER A,VILICH V,SIKORA R A.Detection of fungi in planta:Effectiveness of surface sterilization methods[J]. Mycological research, 2001,105(5):563-566. [7] 李冬利,张庆波,陈玉婵,等. 白木香内生真菌抗肿瘤抗菌活性的筛选研究[J]. 微生物学杂志,2009,29(5):26-29. [8] JOUDA J B, KUSARI S,LAMSHÖFT M,et al. Penialidins A-C with strong antibacterial activities from Penicillium sp., an endophytic fungus harboring leaves of Garcinia nobilis[J].Fitoterapia,2014, 98:209-214. [9] 邓祖军, 曹理想, 谭红铭,等. 红树林内生真菌抗细菌和抗真菌活性的初步研究[J]. 广东药学院学报, 2007, 23(5):563-567. [10] ROSARIO N,ANTONIO T.Bioactive compounds produced by strains of Penicillium and Talaromyces of marine origin[J].Marine drugs, 2016, 14(2):37-72. [11] 谢红艳. 我国部分区域链格孢属(Alternaria Nees)真菌的资源调查与形态和分子鉴定研究[D]. 贵阳:贵州大学, 2006. [12] 陈俊, 冯宇美, 杨雪萍,等. 链格孢属MNP801海洋真菌抗肿瘤活性代谢产物研究[A].中国化学会第九届全国天然有机化学学术会议论文集[C]. 北京:中国化学会,2012.219. [13] GAMMELSRUD A, SOLHAUG A, DENDELÉ, et al. Enniatin B-induced cell death and inflammatory responses in RAW 267.4 murine macrophages[J]. Toxicolgy applied pharmacology, 2012, 261(1):74-87. [14] 张弘弛, 刘瑞, 李慧, 等. 拮抗皮革霉变的黄芪内生真菌AR07抑菌成分的分离鉴定[J].中国皮革,2017(5):32-36,40. [15] GONZÁLEZ-LOBATO L, REAL R, PRIETO J, et al. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C[J]. European journal of pharmacology, 2010, 644(1-3):41-48. |